Annual report
4885.TEDINET S100YYBG
Period2025-06-01 → 2026-05-31
Filed2026-08-25
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed
Key figures · 93
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥7.8bn | 2025-06-01 → 2026-05-31 | Standalone | Net sales |
| Revenue | ¥6.7bn | 2024-06-01 → 2025-05-31 | Standalone | Net sales |
| Revenue | ¥6.4bn | 2023-06-01 → 2024-05-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥6.3bn | 2022-06-01 → 2023-05-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥5.7bn | 2021-06-01 → 2022-05-31v | Standalone | Net sales (5-year summary) |
| Operating income | ¥743m | 2025-06-01 → 2026-05-31 | Standalone | Operating income |
| Operating income | ¥432m | 2024-06-01 → 2025-05-31 | Standalone | Operating income |
| Ordinary income | ¥707m | 2025-06-01 → 2026-05-31 | Standalone | Ordinary income |
| Ordinary income | ¥430m | 2024-06-01 → 2025-05-31 | Standalone | Ordinary income |
| Ordinary income | ¥428m | 2023-06-01 → 2024-05-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥351m | 2022-06-01 → 2023-05-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥423m | 2021-06-01 → 2022-05-31v | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥328m | 2025-06-01 → 2026-05-31 | Standalone | Income before income taxes |
| Profit before tax | ¥350m | 2024-06-01 → 2025-05-31 | Standalone | Income before income taxes |
| Net income | ¥163m | 2025-06-01 → 2026-05-31 | Standalone | Profit loss |
| Net income | ¥241m | 2024-06-01 → 2025-05-31 | Standalone | Profit loss |
| Net income | ¥330m | 2023-06-01 → 2024-05-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥256m | 2022-06-01 → 2023-05-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥456m | 2021-06-01 → 2022-05-31v | Standalone | Net income loss (5-year summary) |
| Total assets | ¥6.4bn | at 2026-05-31 | Standalone | Assets |
| Total assets | ¥5.3bn | at 2025-05-31 | Standalone | Assets |
| Total assets | ¥5.1bn | at 2024-05-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥4.9bn | at 2023-05-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥4.8bn | at 2022-05-31v | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥3.8bn | at 2026-05-31 | Standalone | Liabilities |
| Total liabilities | ¥2.8bn | at 2025-05-31 | Standalone | Liabilities |
| Net assets / equity | ¥2.6bn | at 2026-05-31 | Standalone | Net assets |
| Net assets / equity | ¥2.5bn | at 2025-05-31 | Standalone | Net assets |
| Net assets / equity | ¥2.3bn | at 2024-05-31v | Standalone | Net assets |
| Net assets / equity | ¥1.9bn | at 2023-05-31v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥1.7bn | at 2022-05-31v | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥1.9bn | at 2026-05-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥1.1bn | at 2025-05-31 | Standalone | Cash and deposits |
| Cash & equivalents | ¥1.9bn | at 2026-05-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥1.0bn | at 2025-05-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥1.1bn | at 2024-05-31v | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥853m | at 2023-05-31v | Standalone | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥865m | at 2022-05-31v | Standalone | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥808m | 2025-06-01 → 2026-05-31 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | ¥216m | 2024-06-01 → 2025-05-31 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | ¥638m | 2023-06-01 → 2024-05-31v | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥317m | 2022-06-01 → 2023-05-31v | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥525m | 2021-06-01 → 2022-05-31v | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥238m | 2025-06-01 → 2026-05-31 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥371m | 2024-06-01 → 2025-05-31 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥232m | 2023-06-01 → 2024-05-31v | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥162m | 2022-06-01 → 2023-05-31v | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥176m | 2021-06-01 → 2022-05-31v | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥318m | 2025-06-01 → 2026-05-31 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | ¥123m | 2024-06-01 → 2025-05-31 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | −¥210m | 2023-06-01 → 2024-05-31v | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥172m | 2022-06-01 → 2023-05-31v | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥484m | 2021-06-01 → 2022-05-31v | Standalone | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥40.58 | 2025-06-01 → 2026-05-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥60.42 | 2024-06-01 → 2025-05-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥83.42 | 2023-06-01 → 2024-05-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥67.94 | 2022-06-01 → 2023-05-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥123.79 | 2021-06-01 → 2022-05-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥39.99 | 2025-06-01 → 2026-05-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥59.49 | 2024-06-01 → 2025-05-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥81.86 | 2023-06-01 → 2024-05-31v | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥64.12 | 2022-06-01 → 2023-05-31v | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥112.56 | 2021-06-01 → 2022-05-31v | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥26 | 2025-06-01 → 2026-05-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥25 | 2024-06-01 → 2025-05-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥22 | 2023-06-01 → 2024-05-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥19 | 2022-06-01 → 2023-05-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥19 | 2021-06-01 → 2022-05-31v | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥640.13 | at 2026-05-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥612.4 | at 2025-05-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥571.26 | at 2024-05-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥487.25 | at 2023-05-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥450.37 | at 2022-05-31v | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 40.6% | at 2026-05-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 46.6% | at 2025-05-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 44.9% | at 2024-05-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 38.7% | at 2023-05-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 35.0% | at 2022-05-31v | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 6.5% | 2025-06-01 → 2026-05-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 10.2% | 2024-06-01 → 2025-05-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 15.8% | 2023-06-01 → 2024-05-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 14.3% | 2022-06-01 → 2023-05-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 30.3% | 2021-06-01 → 2022-05-31v | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 4,095,500 | at 2026-05-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 4,095,500 | at 2025-05-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 4,095,500 | at 2024-05-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 4,095,500 | at 2023-05-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 4,095,500 | at 2022-05-31v | Standalone | Total number of issued shares (5-year summary) |
| Employees | 199 | at 2026-05-31 | Standalone | Number of employees |
| Employees | 203 | at 2025-05-31 | Standalone | Number of employees |
| Employees | 205 | at 2024-05-31v | Standalone | Number of employees |
| Employees | 205 | at 2023-05-31v | Standalone | Number of employees |
| Employees | 197 | at 2022-05-31v | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 53
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment assets | at 2026-05-31 | ¥2.7bn |
| Chemical Products Businessreportable segment | capex | 2025-06-01 → 2026-05-31 | ¥70m |
| Chemical Products Businessreportable segment | depreciation | 2025-06-01 → 2026-05-31 | ¥79m |
| Chemical Products Businessreportable segment | employees | at 2026-05-31 | 52 pure |
| Chemical Products Businessreportable segment | revenue | 2025-06-01 → 2026-05-31 | ¥2.7bn |
| Chemical Products Businessreportable segment | revenue external | 2025-06-01 → 2026-05-31 | ¥2.7bn |
| Chemical Products Businessreportable segment | segment assets | at 2026-05-31 | ¥1.3bn |
| Chemical Products Businessreportable segment | segment profit | 2025-06-01 → 2026-05-31 | ¥91m |
| Healthy Food Businessreportable segment | capex | 2025-06-01 → 2026-05-31 | ¥10m |
| Healthy Food Businessreportable segment | depreciation | 2025-06-01 → 2026-05-31 | ¥12m |
| Healthy Food Businessreportable segment | employees | at 2026-05-31 | 12 pure |
| Healthy Food Businessreportable segment | revenue | 2025-06-01 → 2026-05-31 | ¥1.2bn |
| Healthy Food Businessreportable segment | revenue external | 2025-06-01 → 2026-05-31 | ¥1.2bn |
| Healthy Food Businessreportable segment | segment assets | at 2026-05-31 | ¥230m |
| Healthy Food Businessreportable segment | segment profit | 2025-06-01 → 2026-05-31 | ¥18m |
| Pharmaceutical Businessreportable segment | capex | 2025-06-01 → 2026-05-31 | ¥166m |
| Pharmaceutical Businessreportable segment | depreciation | 2025-06-01 → 2026-05-31 | ¥99m |
| Pharmaceutical Businessreportable segment | employees | at 2026-05-31 | 52 pure |
| Pharmaceutical Businessreportable segment | revenue | 2025-06-01 → 2026-05-31 | ¥4.0bn |
| Pharmaceutical Businessreportable segment | revenue external | 2025-06-01 → 2026-05-31 | ¥4.0bn |
| Pharmaceutical Businessreportable segment | segment assets | at 2026-05-31 | ¥2.2bn |
| Pharmaceutical Businessreportable segment | segment profit | 2025-06-01 → 2026-05-31 | ¥634m |
| Total Of Reportable Segments And Otherssegment total | capex | 2025-06-01 → 2026-05-31 | ¥246m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2025-06-01 → 2026-05-31 | ¥191m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-06-01 → 2026-05-31 | ¥7.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-06-01 → 2026-05-31 | ¥7.8bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2026-05-31 | ¥3.7bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-06-01 → 2026-05-31 | ¥743m |
| Reconciling Itemsreconciling | segment assets | at 2025-05-31 | ¥1.7bn |
| Chemical Products Businessreportable segment | capex | 2024-06-01 → 2025-05-31 | ¥78m |
| Chemical Products Businessreportable segment | depreciation | 2024-06-01 → 2025-05-31 | ¥61m |
| Chemical Products Businessreportable segment | revenue | 2024-06-01 → 2025-05-31 | ¥2.4bn |
| Chemical Products Businessreportable segment | revenue external | 2024-06-01 → 2025-05-31 | ¥2.4bn |
| Chemical Products Businessreportable segment | segment assets | at 2025-05-31 | ¥1.1bn |
| Chemical Products Businessreportable segment | segment profit | 2024-06-01 → 2025-05-31 | ¥57m |
| Healthy Food Businessreportable segment | capex | 2024-06-01 → 2025-05-31 | ¥33m |
| Healthy Food Businessreportable segment | depreciation | 2024-06-01 → 2025-05-31 | ¥28m |
| Healthy Food Businessreportable segment | revenue | 2024-06-01 → 2025-05-31 | ¥1.0bn |
| Healthy Food Businessreportable segment | revenue external | 2024-06-01 → 2025-05-31 | ¥1.0bn |
| Healthy Food Businessreportable segment | segment assets | at 2025-05-31 | ¥334m |
| Healthy Food Businessreportable segment | segment profit | 2024-06-01 → 2025-05-31 | −¥99m |
| Pharmaceutical Businessreportable segment | capex | 2024-06-01 → 2025-05-31 | ¥182m |
| Pharmaceutical Businessreportable segment | depreciation | 2024-06-01 → 2025-05-31 | ¥74m |
| Pharmaceutical Businessreportable segment | revenue | 2024-06-01 → 2025-05-31 | ¥3.2bn |
| Pharmaceutical Businessreportable segment | revenue external | 2024-06-01 → 2025-05-31 | ¥3.2bn |
| Pharmaceutical Businessreportable segment | segment assets | at 2025-05-31 | ¥2.1bn |
| Pharmaceutical Businessreportable segment | segment profit | 2024-06-01 → 2025-05-31 | ¥474m |
| Total Of Reportable Segments And Otherssegment total | capex | 2024-06-01 → 2025-05-31 | ¥292m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2024-06-01 → 2025-05-31 | ¥162m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-06-01 → 2025-05-31 | ¥6.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-06-01 → 2025-05-31 | ¥6.7bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2025-05-31 | ¥3.5bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-06-01 → 2025-05-31 | ¥432m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,218
| Item | Context | Value | Unit |
|---|---|---|---|
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row2Member | Original text (Japanese)無 | |
| Basic policy on human resources strategy employees etc (text) | FilingDateInstant | Text · Plus | |
| Information about employees (text) | FilingDateInstant | Text · Plus | |
| Regulations in accordance with which financial statements have been prepared financial information | CurrentYearDuration | Text · Plus | |
| Note on independent audit financial information | CurrentYearDuration | Text · Plus | |
| Description of fact that consolidated financial statements have not been prepared financial information | CurrentYearDuration | Original text (Japanese)当社は子会社がありませんので、連結財務諸表を作成しておりません。 | |
| Remarkable efforts to ensure fair presentation of consolidated financial statements etc financial information | CurrentYearDuration | Text · Plus | |
| Balance sheet (text) | CurrentYearDuration | Text · Plus | |
| Statement of income (text) | CurrentYearDuration | Text · Plus | |
| Detailed schedule of manufacturing cost (text) | CurrentYearDuration | Text · Plus | |
| Statement of changes in equity (text) | CurrentYearDuration | Text · Plus | |
| Statement of cash flows (text) | CurrentYearDuration | Text · Plus | |
| Notes significant accounting policies financial statements (text) | CurrentYearDuration | Text · Plus | |
| Significant accounting estimates financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes new accounting standards not yet applied financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding trade notes receivable discounted or transferred by endorsement (text) | CurrentYearInstant_NonConsolidatedMember | Text · Plus | |
| Notes regarding pledged assets (text) | CurrentYearInstant_NonConsolidatedMember | Text · Plus | |
| Debtors notes regarding overdraft contracts and or loan commitments (text) | CurrentYearInstant_NonConsolidatedMember | Text · Plus | |
| Notes regarding financial covenant (text) | CurrentYearInstant_NonConsolidatedMember | Text · Plus | |
| Notes regarding promissory notes due on balance sheet date (text) | CurrentYearInstant_NonConsolidatedMember | Text · Plus | |
| Notes regarding amount of revenue from contracts with customers (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Notes regarding write downs of inventories (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Research and development expenses included in general and administrative expenses and manufacturing cost for current period (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Notes regarding gain on sales of property plant and equipment (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Notes regarding loss on disposal of property plant and equipment (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Notes regarding impairment loss (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Notes regarding issued shares and treasury shares (text) | Prior1YearDuration_NonConsolidatedMember | Text · Plus | |
| Notes regarding new share subscription rights etc (text) | Prior1YearDuration_NonConsolidatedMember | Text · Plus | |
| Notes regarding dividend (text) | Prior1YearDuration_NonConsolidatedMember | Text · Plus | |
| Notes regarding issued shares and treasury shares (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Notes regarding new share subscription rights etc (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Notes regarding dividend (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Reconciliation of ending balance of cash and cash equivalents with account balances per balance sheet (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Notes leases financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes financial instruments financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes securities financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes retirement benefits financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes share options etc financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes tax effect accounting financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes asset retirement obligations financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes revenue recognition financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes segment information etc financial statements (text) | CurrentYearDuration | Text · Plus | |
| Description of reportable segments (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Explanation of measurements of sales profit loss asset liability and other items for each reportable segment (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Footnotes regarding segment information table (text) | Prior1YearDuration_NonConsolidatedMember | Text · Plus | |
| Footnotes regarding segment information table (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Information for each product or service (text) | Prior1YearDuration_NonConsolidatedMember | Text · Plus | |
| Revenues from external customers information for each region (text) | Prior1YearDuration_NonConsolidatedMember | Text · Plus | |
| Property plant and equipment information for each region (text) | Prior1YearDuration_NonConsolidatedMember | Text · Plus | |
| Information for each of main customers (text) | Prior1YearDuration_NonConsolidatedMember | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 13 of 13 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |